We use cookies to improve your browsing experience and provide meaningful content. Read our cookie policy. Accept
  •  Customer Login
  • Register
  •  View Cart (0)
  •  Customer Login
  • Register
  •  View Cart (0)

Takara Bio
  • Products
  • Services & Support
  • Learning centers
  • APPLICATIONS
  • About
  • Contact Us

Clontech Takara Cellartis

Close

  • ‹ Back to Immune Profiling
  • Track B-cell changes in your mouse model
  • Efficient and sensitive profiling of human B-cell receptor repertoire
  • TCRv2 kit validated for rhesus macaque samples
  • Improved TCR repertoire profiling from mouse samples (bulk)
  • TCR repertoire profiling from mouse samples (bulk)
  • BCR repertoire profiling from mouse samples (bulk)
  • Improved TCR repertoire profiling from human samples (bulk)
  • TCR repertoire profiling from human samples (single cells)
  • BCR repertoire profiling from human samples (bulk)
hBCRv2 product page SMART-Seq Human BCR (with UMIs)
Home › Learning centers › Next-generation sequencing › Technical notes › Immune Profiling › Efficient and sensitive profiling of human B-cell receptor repertoire

Technical notes

  • DNA-seq
    • Next-gen WGA method for CNV and SNV detection from single cells
    • Low-input whole-exome sequencing
    • DNA-seq from FFPE samples
    • Low cell number ChIP-seq using ThruPLEX DNA-Seq
    • Detection of low-frequency variants using ThruPLEX Tag-Seq FLEX
    • ThruPLEX FLEX outperforms NEBNext Ultra II
    • Streamlined DNA-seq from challenging samples
    • High-resolution CNV detection using PicoPLEX Gold DNA-Seq
    • ThruPLEX FLEX data sheet
    • Low-volume DNA shearing for ThruPLEX library prep
    • NGS library prep with enzymatic fragmentation
    • Comparing ThruPLEX FLEX EF to Kapa and NEBNext
  • Immune Profiling
    • Track B-cell changes in your mouse model
    • Efficient and sensitive profiling of human B-cell receptor repertoire
    • TCRv2 kit validated for rhesus macaque samples
    • Improved TCR repertoire profiling from mouse samples (bulk)
    • TCR repertoire profiling from mouse samples (bulk)
    • BCR repertoire profiling from mouse samples (bulk)
    • Improved TCR repertoire profiling from human samples (bulk)
    • TCR repertoire profiling from human samples (single cells)
    • BCR repertoire profiling from human samples (bulk)
  • Epigenetic sequencing
    • ChIP-seq libraries for transcription factor analysis
    • ChIP-seq libraries from ssDNA
    • Full-length small RNA libraries
    • Methylated DNA-seq with MBD2
  • Reproductive health technologies
    • Embgenix ESM Screen
    • Embgenix PGT-A
New products
Need help?
Contact Sales
hBCRv2 product page SMART-Seq Human BCR (with UMIs)
Tech Note

Efficient and sensitive profiling of human BCR repertoire

Next generation sequencing (NGS) approaches for profiling human B-cell receptors (BCRs) yield powerful insights into the immune response of healthy individuals and those affected by diseases. To fully harness the potential of such profiling, sensitive, reliable techniques to amplify BCR repertoires are needed.

SMART-Seq Human BCR (with UMIs) (referred to as “hBCRv2”) can reproducibly detect all BCR clonotypes, even those with low abundance, with best-in-class sensitivity. Using a high-throughput mRNA-based method for human BCR profiling, you can amplify variable regions of all BCR isotypes, both heavy and light chains.

Industry-leading features of hBCRv2 include:

  • Increased accuracy—unique molecular identifier (UMI)-based PCR error correction
  • Sequencing flexibility—sequence either the full-length V(D)J region or the CDR3 only and multiplex with up to 384 unique dual indexes (UDIs)
  • Wide input range—high-integrity RNA from PBMCs (10 ng–1 µg), B cells (1–100 ng), spleen or bone marrow (up to 10 ng), or whole blood (up to 100 ng)
  • Detection of all BCR isotypes—sequence all heavy and light chains seamlessly with pooled primers
Introduction Results Conclusion Materials and Methods

Introduction  

Basics of the B-cell repertoire

B cells are vital members of the adaptive humoral immune response. They express receptors (BCRs) on their surface. BCRs recognize the unique molecular patterns of invading pathogens and block the spread of infection by secreting neutralizing antibodies. A developing B cell undergoes recombination; afterward, the BCR has two identical heavy chains (generated by the recombination of V, D, and J gene segments) and two identical light chains (generated by the recombination of V and J gene segments). 

The diverse collection of clonotypes—the BCR repertoire—is key to shaping immunity. Profiling this repertoire with NGS has provided valuable insights, such as informing the design of therapeutic interventions against SARS-CoV-2. Current technologies are limited in their ability to generate data accurately and reproducibly for all human BCR heavy and light chains. There is an urgent need for both academic and clinical researchers to get a precise readout of BCR sequences for a good understanding of B cell responses in normal and disease states.

SMART-Seq Human BCR (with UMIs) kit chemistry

We developed a refined kit for profiling the BCR repertoire to satisfy this need. It leverages SMART technology (Switching Mechanism at 5′ End of RNA Template) and pairs NGS with a 5′ RACE approach. This optimized chemistry for BCR profiling delivers sensitivity, accuracy, and reliability. The 5′-RACE method used in hBCRv2 does not require any prior knowledge of the BCR sequences, reduces variability, and allows for priming from the constant region of all heavy and light chains (Figure 1).

Figure 1. SMART-Seq Human BCR (with UMIs) workflow. dT-primed, first-strand cDNA synthesis is followed by two rounds of successive PCR for amplification of cDNA sequences. After post-PCR purification, size selection, and quality analysis, the library is ready for sequencing.

When used with CogentIP, PCR duplicates and sequencing errors can be detected and removed from the data, leading to more accurate and reliable clonotype calling and quantification. The addition of the UDIs lets researchers pool multiple samples—currently up to 384—while providing greater confidence in sample integrity when sequencing on a patterned Illumina flow cell. We have improved our chemistry from our initial human BCR kit (hBCRv1) to make the BCR libraries compatible with any Illumina sequencer, allowing researchers to save on sequencing costs and increase sample multiplexing on high-throughput sequencers such as the NovaSeq™ system. Full-length V(D)J transcript information can be obtained when libraries are sequenced on the MiSeq® or NextSeq® system, or the CDR3 region using shorter sequencing read lengths on any sequencer. hBCRv2 is designed to generate a consistent library yield from 10 ng–1 ug of PBMC RNA, 1 ng–100 ng of B cell RNA, or up to 100 ng of whole blood RNA, ensuring a sufficient yield for any sequencing configurations. We have also deployed pooled primers to greatly simplify the workflow and allow researchers to study heavy chains found in all isotypes (IgG, IgM, IgD, IgA, and IgE) and immunoglobulin light chain (IgK and IgL) in a much more seamless way.

Results  

More sensitive and comprehensive BCR profiling with hBCRv2

To evaluate the sensitivity of hBCRv2, libraries were prepared from 10, 100, and 1,000 ng of RNA extracted from PBMCs, generating approximately 2 million, 6 million, and 12 million sequencing reads, respectively. Clonotype counts from both heavy chain (IgG/M/D/A/E) and light chain (IgK and IgL) consistently increase as the amount of RNA input increases (Figure 2, Panel A). Chord diagrams for both heavy-chain (HC) and light-chain (LC) libraries prepared from 10 ng input showed confident detection of clonotypes with varying abundance, as indicated by chord of various thickness (Figure 2, Panel B).

Figure 2. hBCRv2 detected all BCR clonotypes with confidence. Panel A. Detection of all BCR clonotypes for both heavy chain (IgA/D/E/G/M) and light chain (IgK/L) by hBCRv2 in 10, 100, and 1,000 ng input of PBMC RNA. Comparison across various RNA inputs shows consistent increase in clonotype count with increase in RNA input. Panel B. Chord diagram for heavy-chain (HC) and light-chain (LC) isotypes of 10 ng input of PBMC RNA.

To demonstrate how SMART technology combined with 5′ RACE is the best-in-class approach for BCR profiling, we prepared BCR libraries using 10 ng of human PBMC total RNA according to the manufacturer’s instructions. With sequencing reads downsampled to ~1 million for Company N libraries and 500,000 each for heavy- and light-chain libraries for hBCRv2, we found a 127% increase in clonotype counts against Company N, manifesting superior data quality (Figure 3).

Figure 3. Best-in-class sensitivity of hBCRv2. Libraries were generated using 10 ng of human PBMC total RNA according to the manufacturer’s instructions. The resulting cDNA libraries were sequenced on Illumina platform. Sequencing outputs were downsampled to ~1 million for Company N libraries and 500,000 each for heavy and light chain libraries for hBCRv2. In comparison to Company N, hBCRv2 generated approximately 9.5K and 22.9K clonotypes for heavy-chain (HC) and light-chain (LC) isotypes respectively, representing a 127% increase against Company N.

A streamlined workflow to profile all heavy chains

One of the most important improvements we made in hBCRv2 as compared to hBCRv1 was a much more simplified workflow enabling detection of all BCR heavy chains. While the previous kit only allowed researchers to sequence IgG and IgM for the heavy chains, hBCRv2 can profile all BCR heavy chains (i.e., IgG/M/D/A/E) with great confidence. Compared with hBCRv1, hBCRv2 also displays much higher sensitivity, as indicated by more clonotypes detected for both heavy and light chains at the same sequencing depth (Figure 4). Besides revamped chemistry to support ultra-sensitive readout of more BCR clonotypes, we also redesigned the workflow with pooled primers, allowing researchers to generate all BCR heavy-chain libraries in one reaction.

Figure 4. More clonotypes captured by a simpler workflow. Libraries were generated from 1 ng of B-cell RNA using the hBCRv1 (light blue) and hBCRv2 (dark blue) workflow. The resulting cDNA libraries were sequenced on an Illumina MiSeq sequencer. Sequencing data was downsampled to 250,000 for each heavy and light chain of hBCRv1 libraries and 500,000 for each heavy and light chain of hBCRv2 libraries. Data was analyzed using CogentIP. Here, the bar graphs illustrate that higher numbers of and more diverse clonotypes were detected with the improved hBCRv2 chemistry.

hBCRv2 provides accurate and unbiased amplification of low-abundance clonotypes

Another key benefit of hBCRv2 is its superior accuracy powered by UMIs. To evaluate how UMIs guaranteed accurate profiling of BCR clonotypes, we spiked 100, 10, 1, and 0.1 pg of RNA extracted from the TIB-190 cell line into 10 ng of PBMC RNA. BCR libraries were prepared with hBCRv2 and sequenced on an Illumina MiSeq sequencer. During data analysis, libraries were normalized to 200,000 reads and clonotype counts were measured after UMI-based consensus collapse in CogentIP. The ratio of detected TIB-190 reads versus total reads showed good correlation with the spike-in percentage of TIB-190 RNA (Figure 5). This result indicates that UMI-powered analysis with hBCRv2 enables researchers to identify low-abundance BCR clonotypes with great confidence and accuracy.

Figure 5. Successful identification of low-abundance clonotypes. 100, 10, 1, and 0.1 pg of RNA extracted from the TIB-190 cell line were spiked into 10 ng of PBMC RNA. Panel A. Clone counts at different spike-in levels are listed in the table. Libraries were normalized to 200,000 reads, and all counts were measured after UMI-based consensus collapse. Panel B. Calculated correlation between spike-in RNA proportions and detected clonotype frequencies. Both axes are logarithmically transformed.

Best-in-class reproducibility is needed for biomarker discoveries in clinical research

Immune repertoire sequencing, such as BCR profiling, has been widely used for biomarker discoveries in clinical research, making it extremely important that the underlying workflow can generate reproducible and high-quality data each time. To evaluate the reproducibility of hBCRv2, we prepared BCR libraries from 10 ng of PBMC RNA and 1 ng of B-cell RNA using the hBCRv2 protocol. Technical replicates prepared with 10 ng of PBMC RNA were sequenced on a MiSeq sequencer with 300-cycle and 600-cycle kits. The Venn diagram illustrates 87% clonotype overlap (Figure 6, Panel A). Libraries prepared using B-cell RNA also displayed great reproducibility, as indicated by ≥85% clonotype overlap between the libraries sequenced on different platforms (Figure 6, Panel B).

Figure 6. Evaluation of clonotype reproducibility. BCR profiling libraries from 10 ng of PBMC RNA and 1 ng of B-cell RNA were prepared using the hBCRv2 workflow. Panel A. Technical replicates prepared with 10 ng PBMC RNA were sequenced on the Illumina MiSeq platform. Data generated were downsampled to 1 million reads and analyzed using CogentIP. The Venn diagram illustrates 87% clonotype overlap between technical replicates libraries. Panel B. Libraries prepared using 1 ng B-cell RNA were sequenced on the same MiSeq sequencer with both a 600-cycle V3 cartridge and a 300-cycle V2 cartridge, as well as on the Illumina MiniSeq™ platform with a 300-cycle cartridge. Data generated were downsampled to 1 million reads and analyzed using CogentIP. Venn diagrams show ≥85% clonotype overlap between the libraries sequenced on different platforms.

Conclusion  

SMART-Seq Human BCR (with UMIs) is an innovative and powerful tool for profiling human B-cell receptors. By leveraging SMART technology and combining a 5′-RACE approach with gene-specific amplification, this workflow captures complete V(D)J variable regions of BCRs and is optimized for sensitive and reproducible clonotype detection. Incorporation of UMIs during reverse transcription also enhances the accuracy of this workflow by removing sequencing reads derived from PCR amplification bias. Furthermore, we have also modified the workflow with pooled primers so researchers can enjoy a much easier protocol with all BCR chains profiled in one reaction. Incorporating UDIs into the libraries allows for both pooling of up to 384 samples and sequencing on patterned flow cells without worrying about index hopping.

Materials and Methods  

BCR libraries were prepared from human PBMC total RNA (Takara Bio, Cat. # 636592) and human B-Cell (CD19+) total RNA (Miltenyi Biotech, Cat. # 130-0930169). For the sensitivity test, total RNA from the TIB-190 B-cell carcinoma cell line (ATCC) was spiked into 10 ng of PBMC RNA at the listed concentrations. Total RNA from TIB-190 cells was extracted using the NucleoSpin RNA plus kit (Takara Bio, Cat. # 740984.50).

All BCR libraries were generated using SMART-Seq Human BCR (with UMIs), as per the user manual. Following purification and size selection, libraries were quantified using the Qubit and Agilent Bioanalyzer 2100. Sequencing was performed on a MiSeq sequencer with 600-cycle V3 cartridges (Illumina, Cat. # MS-102-3003), a MiSeq sequencer with 300-cycle V3 cartridges (Illumina, Cat. # MS-102-3001), and a MiniSeq sequencer with 300-cycle cartridges (Illumina, Cat. # FC-420-1002). Data analysis was completed using Cogent NGS Immune Profiler. The report of heavy-chain and light-chain clonotypes from 10 ng of PBMC RNA generated by CogentIP was uploaded to VDJviz browser for chord diagram visualization.

Related Products

Cat. # Product Size Price License Quantity Details
634777 SMART-Seq® Human BCR (with UMIs) 24 Rxns USD $1406.00

License Statement

ID Number  
392 This Product is protected by one or more patents from the family consisting of:US10941397, People's Republic of China Patent: ZL201480057094.4, US10781443, US10954510, DE602014069266.4, EP3058104, FR3058104, UK3058104, JP6602294, SE3058104, CA2923812, and any corresponding patents, divisionals, continuations, patent applications and foreign filings sharing common priority with the same family. Information on relevant patents and licenses for this product may be found at: https://www.takarabio.com/patents. 
455 This product is sold under license from Becton Dickinson and Co., and may be the subject of U.S. Patent Nos.: 8,835,358; 9,290,809; 9,315,857; 9,708,659; 9,845,502; 10,047,394; 10,059,991; 10,202,646; 10,392,661; 10,619,203; 11,970,737; 12,060,607; and its foreign counterparts.

SMART-Seq Human BCR (with UMIs) generates oligo(dT)-primed, full-length mRNA-seq libraries for all BCR heavy (IgG/M/D/E/A) and light (IgK/L) chains. The incorporation of unique molecular identifiers (UMIs) provides greater accuracy for quantitative gene expression analysis across samples while controlling for PCR errors and amplification biases. Up to 384 multiplexed, Illumina-ready sequencing libraries can be obtained using the Unique Dual Index Kits (Cat. # 634752–56). This kit offers an end-to-end solution including cDNA synthesis, library preparation, and data analysis with our free Cogent NGS bioinformatics tools.

Notice to purchaser

Our products are to be used for Research Use Only. They may not be used for any other purpose, including, but not limited to, use in humans, therapeutic or diagnostic use, or commercial use of any kind. Our products may not be transferred to third parties, resold, modified for resale, or used to manufacture commercial products or to provide a service to third parties without our prior written approval.

Documents Components You May Also Like Image Data

Back

634777: SMART-Seq Human BCR (with UMIs)

634777: SMART-Seq Human BCR (with UMIs)

Back

Sensitive and reproducible BCR clonotype detection

Sensitive and reproducible BCR clonotype detection

Sensitive and reproducible clonotype detection from a broad range of RNA amounts. Human BCR heavy chain (IgA/D/E/G/M) and light chain (IgK/L) libraries were generated from 10, 100, and 1,000 ng of total human PBMC RNA using SMART-Seq Human BCR (with UMIs). The sequence reads were processed using Cogent NGS Immune Profiler Software.

Back

Schematic of technology and workflow for SMART-Seq Human BCR (with UMIs)

Schematic of technology and workflow for SMART-Seq Human BCR (with UMIs)

Schematic of technology and workflow for SMART-Seq Human BCR (with UMIs). Input RNA or cells are oligo-dT primed using the dT Primer (dark blue). Following oligo dT-priming, SmartScribe Reverse Transcriptase performs first strand cDNA synthesis on input RNA or cells and adds non-templated nucleotides to the 5’ end of each cDNA molecule (XXXXX). Upon reaching the 5’ end of the RNA template, the SMART UMI Oligo anneals to the non-templated nucleotides (XXXXX), incorporating the UMI (yellow) and partial Illumina adapter (light green) complementary to the hBCR PCR1 Universal Forward primer. Following reverse transcription, semi-nested PCR is performed to amplify BCR cDNAs. In PCR1, the hBCR PCR1 Universal Forward primer anneals to the complementary sequence carried by the SMART UMI Oligo (light green), incorporating the Illumina Read2 sequence (dark green). The hBCR PCR1 Reverse primer (orange) anneals to sequences in the constant regions of BCR cDNAs to amplify the entire BCR V(D)J region. During the PCR2, the nested hBCR LC (light chain) or hBCR HC (heavy chain) PCR2 Reverse primers anneal to sequences in BCR constant regions that are internal to the sequences bound by the hBCR PCR1 Reverse primer and add the Illumina Read 1 sequence (light purple). In the same PCR2 reaction, Unique Dual Index Kit primers anneal to the sequence added by hBCR PCR1 Universal Forward primer or the hBCR LC or HC PCR2 Reverse primers to add Illumina P7-i7 and P5-i5 index sequences (dark blue). The result is a sequencing-ready library that contains the entire BCR light chain and/or heavy chain variable regions with a small portion of the constant region.

Back

Consistency

Consistency
Fig. 2. SMART-Seq Human BCR (with UMIs) shows consistent performance across a variety of inputs. Bar plot showing clonotype counts for human BCR libraries from PBMC RNA (Panel A) and B-cell RNA (Panel B) at various inputs demonstrate a consistent increase in clonotype count with increase in RNA input. Sequencing outputs were down sampled to ~2 million, 6 million and 12 million reads for PBMC RNA and ~1 million, 5 million and 12 million reads for B-cell RNA. Data was processed using Takara Bio’s Immune profiling software (Cogent NGS Immune Profiler). HC=heavy chain, LC=light chain.

Back

Superior data quality

Superior data quality
Fig. 3. Superior data quality with SMART-Seq Human BCR (with UMIs). Significantly higher clonotype counts are observed with the updated SMART-Seq Human BCR (with UMIs) (BCRv2) compared to both the previous version SMARTer Human BCR IgG IgM H/K/L Profiling Kit (BCRv1) and the competitor kit (Company N). Libraries were generated using 10 ng of human PBMC total RNA according to the manufacturer’s instructions and sequenced on the Illumina platform. Panel A. Sequencing outputs were down sampled to ~1 million for all the libraries. BCRv2 generated approximately 550% more clonotypes than previous version. Panel B. Sequencing outputs were down sampled to ~1 million for Company N libraries and 500,000 each for heavy and light chain libraries for BCRv2. In comparison to Company N, BCRv2 generated approximately 9.5K and 22.9K clonotypes for heavy chain (HC) and light chain (LC) isotypes respectively, representing a 127% increase against Company N.

Back

Sensitivity

Sensitivity
Fig. 4. High sensitivity for the identification of low abundance clonotypes. 100pg, 10pg, 1pg and 0.1pg of RNA extracted from the TIB-190 cell line was spiked into 10 ng of PBMC RNA. Panel A. Clone counts at different spike-in levels are listed in the table. Libraries were normalized to 200,000 reads and all counts were measured after UMI-based consensus collapse. Panel B. Calculated correlation between spike-in RNA proportions and detected clonotype frequencies (both axes logarithmically transformed). Linear relationship between spike-in RNA sample (down to 0.001%) and clonotype frequencies observed with SMART-Seq Human BCR (with UMIs).

Back

Performance

Performance
Fig. 5. Highly reproducible BCR profiling with SMART-Seq Human BCR (with UMIs) between replicates and sequencing platforms. BCR profiling libraries from 10 ng of PBMC RNA and 1 ng B-cell RNA were prepared using SMART-Seq Human BCR (with UMIs). Panel A. Technical replicate libraries prepared with 10 ng PBMC RNA sequenced on the Illumina Miseq platform show high clonotype overlap (87%). Panel B. Libraries prepared using 1 ng B-cell RNA sequenced on the Miseq using a 600-cycle V3 cartridge or 300-cycle V2 cartridge as well as on the Miniseq platform show high clonotype overlap. For all libraries, data generated were downsampled to 1,000,000 reads and analyzed using our Cogent NGS Immune Profiler software.

Back

Comparison with previous version of BCR kit

Comparison with previous version of BCR kit
Fig. 6. Comparison with previous version of BCR kit (SMARTer Human BCR IgG IgM H/K/L Profiling Kit)

Back

Reproducibility

Reproducibility
Fig. 7. Correlation analysis for top 100 clonotypes between two biological replicates
634778 SMART-Seq® Human BCR (with UMIs) 96 Rxns USD $4982.00

License Statement

ID Number  
392 This Product is protected by one or more patents from the family consisting of:US10941397, People's Republic of China Patent: ZL201480057094.4, US10781443, US10954510, DE602014069266.4, EP3058104, FR3058104, UK3058104, JP6602294, SE3058104, CA2923812, and any corresponding patents, divisionals, continuations, patent applications and foreign filings sharing common priority with the same family. Information on relevant patents and licenses for this product may be found at: https://www.takarabio.com/patents. 
455 This product is sold under license from Becton Dickinson and Co., and may be the subject of U.S. Patent Nos.: 8,835,358; 9,290,809; 9,315,857; 9,708,659; 9,845,502; 10,047,394; 10,059,991; 10,202,646; 10,392,661; 10,619,203; 11,970,737; 12,060,607; and its foreign counterparts.

SMART-Seq Human BCR (with UMIs) generates oligo(dT)-primed, full-length mRNA-seq libraries for all BCR heavy (IgG/M/D/E/A) and light (IgK/L) chains. The incorporation of unique molecular identifiers (UMIs) provides greater accuracy for quantitative gene expression analysis across samples while controlling for PCR errors and amplification biases. Up to 384 multiplexed, Illumina-ready sequencing libraries can be obtained using the Unique Dual Index Kits (Cat. # 634752–56). This kit offers an end-to-end solution including cDNA synthesis, library preparation, and data analysis with our free Cogent NGS bioinformatics tools.

Notice to purchaser

Our products are to be used for Research Use Only. They may not be used for any other purpose, including, but not limited to, use in humans, therapeutic or diagnostic use, or commercial use of any kind. Our products may not be transferred to third parties, resold, modified for resale, or used to manufacture commercial products or to provide a service to third parties without our prior written approval.

Documents Components You May Also Like Image Data

Back

Sensitive and reproducible BCR clonotype detection

Sensitive and reproducible BCR clonotype detection

Sensitive and reproducible clonotype detection from a broad range of RNA amounts. Human BCR heavy chain (IgA/D/E/G/M) and light chain (IgK/L) libraries were generated from 10, 100, and 1,000 ng of total human PBMC RNA using SMART-Seq Human BCR (with UMIs). The sequence reads were processed using Cogent NGS Immune Profiler Software.

Back

Schematic of technology and workflow for SMART-Seq Human BCR (with UMIs)

Schematic of technology and workflow for SMART-Seq Human BCR (with UMIs)

Schematic of technology and workflow for SMART-Seq Human BCR (with UMIs). Input RNA or cells are oligo-dT primed using the dT Primer (dark blue). Following oligo dT-priming, SmartScribe Reverse Transcriptase performs first strand cDNA synthesis on input RNA or cells and adds non-templated nucleotides to the 5’ end of each cDNA molecule (XXXXX). Upon reaching the 5’ end of the RNA template, the SMART UMI Oligo anneals to the non-templated nucleotides (XXXXX), incorporating the UMI (yellow) and partial Illumina adapter (light green) complementary to the hBCR PCR1 Universal Forward primer. Following reverse transcription, semi-nested PCR is performed to amplify BCR cDNAs. In PCR1, the hBCR PCR1 Universal Forward primer anneals to the complementary sequence carried by the SMART UMI Oligo (light green), incorporating the Illumina Read2 sequence (dark green). The hBCR PCR1 Reverse primer (orange) anneals to sequences in the constant regions of BCR cDNAs to amplify the entire BCR V(D)J region. During the PCR2, the nested hBCR LC (light chain) or hBCR HC (heavy chain) PCR2 Reverse primers anneal to sequences in BCR constant regions that are internal to the sequences bound by the hBCR PCR1 Reverse primer and add the Illumina Read 1 sequence (light purple). In the same PCR2 reaction, Unique Dual Index Kit primers anneal to the sequence added by hBCR PCR1 Universal Forward primer or the hBCR LC or HC PCR2 Reverse primers to add Illumina P7-i7 and P5-i5 index sequences (dark blue). The result is a sequencing-ready library that contains the entire BCR light chain and/or heavy chain variable regions with a small portion of the constant region.

Back

Consistency

Consistency
Fig. 2. SMART-Seq Human BCR (with UMIs) shows consistent performance across a variety of inputs. Bar plot showing clonotype counts for human BCR libraries from PBMC RNA (Panel A) and B-cell RNA (Panel B) at various inputs demonstrate a consistent increase in clonotype count with increase in RNA input. Sequencing outputs were down sampled to ~2 million, 6 million and 12 million reads for PBMC RNA and ~1 million, 5 million and 12 million reads for B-cell RNA. Data was processed using Takara Bio’s Immune profiling software (Cogent NGS Immune Profiler). HC=heavy chain, LC=light chain.

Back

Superior data quality

Superior data quality
Fig. 3. Superior data quality with SMART-Seq Human BCR (with UMIs). Significantly higher clonotype counts are observed with the updated SMART-Seq Human BCR (with UMIs) (BCRv2) compared to both the previous version SMARTer Human BCR IgG IgM H/K/L Profiling Kit (BCRv1) and the competitor kit (Company N). Libraries were generated using 10 ng of human PBMC total RNA according to the manufacturer’s instructions and sequenced on the Illumina platform. Panel A. Sequencing outputs were down sampled to ~1 million for all the libraries. BCRv2 generated approximately 550% more clonotypes than previous version. Panel B. Sequencing outputs were down sampled to ~1 million for Company N libraries and 500,000 each for heavy and light chain libraries for BCRv2. In comparison to Company N, BCRv2 generated approximately 9.5K and 22.9K clonotypes for heavy chain (HC) and light chain (LC) isotypes respectively, representing a 127% increase against Company N.

Back

Sensitivity

Sensitivity
Fig. 4. High sensitivity for the identification of low abundance clonotypes. 100pg, 10pg, 1pg and 0.1pg of RNA extracted from the TIB-190 cell line was spiked into 10 ng of PBMC RNA. Panel A. Clone counts at different spike-in levels are listed in the table. Libraries were normalized to 200,000 reads and all counts were measured after UMI-based consensus collapse. Panel B. Calculated correlation between spike-in RNA proportions and detected clonotype frequencies (both axes logarithmically transformed). Linear relationship between spike-in RNA sample (down to 0.001%) and clonotype frequencies observed with SMART-Seq Human BCR (with UMIs).

Back

Performance

Performance
Fig. 5. Highly reproducible BCR profiling with SMART-Seq Human BCR (with UMIs) between replicates and sequencing platforms. BCR profiling libraries from 10 ng of PBMC RNA and 1 ng B-cell RNA were prepared using SMART-Seq Human BCR (with UMIs). Panel A. Technical replicate libraries prepared with 10 ng PBMC RNA sequenced on the Illumina Miseq platform show high clonotype overlap (87%). Panel B. Libraries prepared using 1 ng B-cell RNA sequenced on the Miseq using a 600-cycle V3 cartridge or 300-cycle V2 cartridge as well as on the Miniseq platform show high clonotype overlap. For all libraries, data generated were downsampled to 1,000,000 reads and analyzed using our Cogent NGS Immune Profiler software.

Back

Comparison with previous version of BCR kit

Comparison with previous version of BCR kit
Fig. 6. Comparison with previous version of BCR kit (SMARTer Human BCR IgG IgM H/K/L Profiling Kit)

Back

Reproducibility

Reproducibility
Fig. 7. Correlation analysis for top 100 clonotypes between two biological replicates

Back

634778: SMART-Seq Human BCR (with UMIs)

634778: SMART-Seq Human BCR (with UMIs)
634776 SMART-Seq® Human BCR (with UMIs) 4 x 96 Rxns Inquire for Quotation

License Statement

ID Number  
392 This Product is protected by one or more patents from the family consisting of:US10941397, People's Republic of China Patent: ZL201480057094.4, US10781443, US10954510, DE602014069266.4, EP3058104, FR3058104, UK3058104, JP6602294, SE3058104, CA2923812, and any corresponding patents, divisionals, continuations, patent applications and foreign filings sharing common priority with the same family. Information on relevant patents and licenses for this product may be found at: https://www.takarabio.com/patents. 
455 This product is sold under license from Becton Dickinson and Co., and may be the subject of U.S. Patent Nos.: 8,835,358; 9,290,809; 9,315,857; 9,708,659; 9,845,502; 10,047,394; 10,059,991; 10,202,646; 10,392,661; 10,619,203; 11,970,737; 12,060,607; and its foreign counterparts.
*

SMART-Seq Human BCR (with UMIs) generates oligo(dT)-primed, full-length mRNA-seq libraries for all BCR heavy (IgG/M/D/E/A) and light (IgK/L) chains. The incorporation of unique molecular identifiers (UMIs) provides greater accuracy for quantitative gene expression analysis across samples while controlling for PCR errors and amplification biases. Up to 384 multiplexed, Illumina-ready sequencing libraries can be obtained using the Unique Dual Index Kits (Cat. # 634752–56). This kit offers an end-to-end solution including cDNA synthesis, library preparation, and data analysis with our free Cogent NGS bioinformatics tools.

Notice to purchaser

Our products are to be used for Research Use Only. They may not be used for any other purpose, including, but not limited to, use in humans, therapeutic or diagnostic use, or commercial use of any kind. Our products may not be transferred to third parties, resold, modified for resale, or used to manufacture commercial products or to provide a service to third parties without our prior written approval.

Documents Components You May Also Like Image Data

Back

Sensitive and reproducible BCR clonotype detection

Sensitive and reproducible BCR clonotype detection

Sensitive and reproducible clonotype detection from a broad range of RNA amounts. Human BCR heavy chain (IgA/D/E/G/M) and light chain (IgK/L) libraries were generated from 10, 100, and 1,000 ng of total human PBMC RNA using SMART-Seq Human BCR (with UMIs). The sequence reads were processed using Cogent NGS Immune Profiler Software.

Back

Schematic of technology and workflow for SMART-Seq Human BCR (with UMIs)

Schematic of technology and workflow for SMART-Seq Human BCR (with UMIs)

Schematic of technology and workflow for SMART-Seq Human BCR (with UMIs). Input RNA or cells are oligo-dT primed using the dT Primer (dark blue). Following oligo dT-priming, SmartScribe Reverse Transcriptase performs first strand cDNA synthesis on input RNA or cells and adds non-templated nucleotides to the 5’ end of each cDNA molecule (XXXXX). Upon reaching the 5’ end of the RNA template, the SMART UMI Oligo anneals to the non-templated nucleotides (XXXXX), incorporating the UMI (yellow) and partial Illumina adapter (light green) complementary to the hBCR PCR1 Universal Forward primer. Following reverse transcription, semi-nested PCR is performed to amplify BCR cDNAs. In PCR1, the hBCR PCR1 Universal Forward primer anneals to the complementary sequence carried by the SMART UMI Oligo (light green), incorporating the Illumina Read2 sequence (dark green). The hBCR PCR1 Reverse primer (orange) anneals to sequences in the constant regions of BCR cDNAs to amplify the entire BCR V(D)J region. During the PCR2, the nested hBCR LC (light chain) or hBCR HC (heavy chain) PCR2 Reverse primers anneal to sequences in BCR constant regions that are internal to the sequences bound by the hBCR PCR1 Reverse primer and add the Illumina Read 1 sequence (light purple). In the same PCR2 reaction, Unique Dual Index Kit primers anneal to the sequence added by hBCR PCR1 Universal Forward primer or the hBCR LC or HC PCR2 Reverse primers to add Illumina P7-i7 and P5-i5 index sequences (dark blue). The result is a sequencing-ready library that contains the entire BCR light chain and/or heavy chain variable regions with a small portion of the constant region.

Back

Consistency

Consistency
Fig. 2. SMART-Seq Human BCR (with UMIs) shows consistent performance across a variety of inputs. Bar plot showing clonotype counts for human BCR libraries from PBMC RNA (Panel A) and B-cell RNA (Panel B) at various inputs demonstrate a consistent increase in clonotype count with increase in RNA input. Sequencing outputs were down sampled to ~2 million, 6 million and 12 million reads for PBMC RNA and ~1 million, 5 million and 12 million reads for B-cell RNA. Data was processed using Takara Bio’s Immune profiling software (Cogent NGS Immune Profiler). HC=heavy chain, LC=light chain.

Back

Superior data quality

Superior data quality
Fig. 3. Superior data quality with SMART-Seq Human BCR (with UMIs). Significantly higher clonotype counts are observed with the updated SMART-Seq Human BCR (with UMIs) (BCRv2) compared to both the previous version SMARTer Human BCR IgG IgM H/K/L Profiling Kit (BCRv1) and the competitor kit (Company N). Libraries were generated using 10 ng of human PBMC total RNA according to the manufacturer’s instructions and sequenced on the Illumina platform. Panel A. Sequencing outputs were down sampled to ~1 million for all the libraries. BCRv2 generated approximately 550% more clonotypes than previous version. Panel B. Sequencing outputs were down sampled to ~1 million for Company N libraries and 500,000 each for heavy and light chain libraries for BCRv2. In comparison to Company N, BCRv2 generated approximately 9.5K and 22.9K clonotypes for heavy chain (HC) and light chain (LC) isotypes respectively, representing a 127% increase against Company N.

Back

Sensitivity

Sensitivity
Fig. 4. High sensitivity for the identification of low abundance clonotypes. 100pg, 10pg, 1pg and 0.1pg of RNA extracted from the TIB-190 cell line was spiked into 10 ng of PBMC RNA. Panel A. Clone counts at different spike-in levels are listed in the table. Libraries were normalized to 200,000 reads and all counts were measured after UMI-based consensus collapse. Panel B. Calculated correlation between spike-in RNA proportions and detected clonotype frequencies (both axes logarithmically transformed). Linear relationship between spike-in RNA sample (down to 0.001%) and clonotype frequencies observed with SMART-Seq Human BCR (with UMIs).

Back

Performance

Performance
Fig. 5. Highly reproducible BCR profiling with SMART-Seq Human BCR (with UMIs) between replicates and sequencing platforms. BCR profiling libraries from 10 ng of PBMC RNA and 1 ng B-cell RNA were prepared using SMART-Seq Human BCR (with UMIs). Panel A. Technical replicate libraries prepared with 10 ng PBMC RNA sequenced on the Illumina Miseq platform show high clonotype overlap (87%). Panel B. Libraries prepared using 1 ng B-cell RNA sequenced on the Miseq using a 600-cycle V3 cartridge or 300-cycle V2 cartridge as well as on the Miniseq platform show high clonotype overlap. For all libraries, data generated were downsampled to 1,000,000 reads and analyzed using our Cogent NGS Immune Profiler software.

Back

Comparison with previous version of BCR kit

Comparison with previous version of BCR kit
Fig. 6. Comparison with previous version of BCR kit (SMARTer Human BCR IgG IgM H/K/L Profiling Kit)

Back

Reproducibility

Reproducibility
Fig. 7. Correlation analysis for top 100 clonotypes between two biological replicates

Back

634776: SMART-Seq Human BCR (with UMIs)

634776: SMART-Seq Human BCR (with UMIs)

*You must be logged in to a Purchasing Account in order to purchase these products online, since the purchase of these products may be restricted depending on your account type. Researchers at not-for-profit accounts receive a limited use license with their purchase of the product. Researchers at for-profit accounts must obtain a license prior to purchase. For details please contact licensing@takarabio.com.

Takara Bio USA, Inc.
United States/Canada: +1.800.662.2566 • Asia Pacific: +1.650.919.7300 • Europe: +33.(0)1.3904.6880 • Japan: +81.(0)77.565.6999
FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC PROCEDURES. © 2025 Takara Bio Inc. All Rights Reserved. All trademarks are the property of Takara Bio Inc. or its affiliate(s) in the U.S. and/or other countries or their respective owners. Certain trademarks may not be registered in all jurisdictions. Additional product, intellectual property, and restricted use information is available at takarabio.com.

Takara Bio

Takara Bio USA, Inc. provides kits, reagents, instruments, and services that help researchers explore questions about gene discovery, regulation, and function. As a member of the Takara Bio Group, Takara Bio USA is part of a company that holds a leadership position in the global market and is committed to improving the human condition through biotechnology. Our mission is to develop high-quality innovative tools and services to accelerate discovery.

FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC PROCEDURES (EXCEPT AS SPECIFICALLY NOTED).

Support
  • Contact us
  • Technical support
  • Customer service
  • Shipping & delivery
  • Sales
  • Feedback
Products
  • New products
  • Special offers
  • Instrument & reagent services
Learning centers
  • NGS
  • Gene function
  • Stem cell research
  • Protein research
  • PCR
  • Cloning
  • Nucleic acid purification
About
  • Our brands
  • Careers
  • Events
  • Blog
  • Need help?
  • Announcements
  • Quality and compliance
  • That's Good Science!
Facebook Twitter  LinkedIn

logo strip white

©2025 Takara Bio Inc. All Rights Reserved.

Region - North America Privacy Policy Terms and Conditions Terms of Use

Top



  • COVID-19 research
  • Viral detection with qPCR
  • SARS-CoV-2 pseudovirus
  • Human ACE2 stable cell line
  • Viral RNA isolation
  • Viral and host sequencing
  • Vaccine development
  • CRISPR screening
  • Drug discovery
  • Immune profiling
  • Publications
  • Next-generation sequencing
  • Spatial omics
  • RNA-seq
  • DNA-seq
  • Single-cell NGS automation
  • Reproductive health
  • Bioinformatics tools
  • Immune profiling
  • Real-time PCR
  • Great value master mixes
  • Signature enzymes
  • High-throughput real-time PCR solutions
  • Detection assays
  • References, standards, and buffers
  • Stem cell research
  • Media, differentiation kits, and matrices
  • Stem cells and stem cell-derived cells
  • mRNA and cDNA synthesis
  • In vitro transcription
  • cDNA synthesis kits
  • Reverse transcriptases
  • RACE kits
  • Purified cDNA & genomic DNA
  • Purified total RNA and mRNA
  • PCR
  • Most popular polymerases
  • High-yield PCR
  • High-fidelity PCR
  • GC rich PCR
  • PCR master mixes
  • Cloning
  • In-Fusion seamless cloning
  • Competent cells
  • Ligation kits
  • Restriction enzymes
  • Nucleic acid purification
  • Automated platforms
  • Plasmid purification kits
  • Genomic DNA purification kits
  • DNA cleanup kits
  • RNA purification kits
  • Gene function
  • Gene editing
  • Viral transduction
  • Fluorescent proteins
  • T-cell transduction and culture
  • Tet-inducible expression systems
  • Transfection reagents
  • Cell biology assays
  • Protein research
  • Purification products
  • Two-hybrid and one-hybrid systems
  • Mass spectrometry reagents
  • Antibodies and ELISAs
  • Primary antibodies and ELISAs by research area
  • Fluorescent protein antibodies
  • New products
  • Special offers
  • OEM
  • Portfolio
  • Process
  • Facilities
  • Request samples
  • FAQs
  • Instrument services
  • Apollo services
  • ICELL8 services
  • SmartChip ND system services
  • Gene and cell therapy manufacturing services
  • Services
  • Facilities
  • Our process
  • Resources
  • Customer service
  • Sales
  • Make an appointment with your sales rep
  • Shipping & delivery
  • Technical support
  • Feedback
  • Online tools
  • GoStix Plus FAQs
  • Partnering & Licensing
  • Vector information
  • Vector document overview
  • Vector document finder
Takara Bio's award-winning GMP-compliant manufacturing facility in Kusatsu, Shiga, Japan.

Partner with Takara Bio!

Takara Bio is proud to offer GMP-grade manufacturing capabilities at our award-winning facility in Kusatsu, Shiga, Japan.

  • Automation systems
  • Shasta Single Cell System introduction
  • SmartChip Real-Time PCR System introduction
  • ICELL8 introduction
  • Next-generation sequencing
  • RNA-seq
  • Technical notes
  • Technology and application overviews
  • FAQs and tips
  • DNA-seq protocols
  • Bioinformatics resources
  • Webinars
  • Spatial biology
  • Real-time PCR
  • Download qPCR resources
  • Overview
  • Reaction size guidelines
  • Guest webinar: extraction-free SARS-CoV-2 detection
  • Technical notes
  • Nucleic acid purification
  • Nucleic acid extraction webinars
  • Product demonstration videos
  • Product finder
  • Plasmid kit selection guide
  • RNA purification kit finder
  • mRNA and cDNA synthesis
  • mRNA synthesis
  • cDNA synthesis
  • PCR
  • Citations
  • PCR selection guide
  • Technical notes
  • FAQ
  • Cloning
  • Automated In-Fusion Cloning
  • In-Fusion Cloning general information
  • Primer design and other tools
  • In‑Fusion Cloning tips and FAQs
  • Applications and technical notes
  • Stem cell research
  • Overview
  • Protocols
  • Technical notes
  • Gene function
  • Gene editing
  • Viral transduction
  • T-cell transduction and culture
  • Inducible systems
  • Cell biology assays
  • Protein research
  • Capturem technology
  • Antibody immunoprecipitation
  • His-tag purification
  • Other tag purification
  • Expression systems
  • Antibodies and ELISA
  • Molecular diagnostics
  • Interview: adapting to change with Takara Bio
  • Applications
  • Solutions
  • Partnering
  • Contact us
  • mRNA and protein therapeutics
  • Characterizing the viral genome and host response
  • Identifying and cloning protein targets
  • Expressing and purifying protein targets
  • Immunizing mice and optimizing vaccines
  • Pathogen detection
  • Sample prep
  • Detection methods
  • Identification and characterization
  • SARS-CoV-2
  • Antibiotic-resistant bacteria
  • Food crop pathogens
  • Waterborne disease outbreaks
  • Viral-induced cancer
  • Immunotherapy research
  • T-cell therapy
  • Antibody therapeutics
  • T-cell receptor profiling
  • TBI initiatives in cancer therapy
  • Cancer research
  • Kickstart your cancer research with long-read sequencing
  • Sample prep from FFPE tissue
  • Sample prep from plasma
  • Cancer biomarker quantification
  • Single cancer cell analysis
  • Cancer transcriptome analysis
  • Cancer genomics and epigenomics
  • HLA typing in cancer
  • Gene editing for cancer therapy/drug discovery
  • Alzheimer's disease research
  • Antibody engineering
  • Sample prep from FFPE tissue
  • Single-cell sequencing
  • Reproductive health technologies
  • Embgenix FAQs
  • Preimplantation genetic testing
  • ESM partnership program
  • ESM Collection Kit forms
  • Infectious diseases
  • Develop vaccines for HIV
Create a web account with us

Log in to enjoy additional benefits

Want to save this information?

An account with takarabio.com entitles you to extra features such as:

•  Creating and saving shopping carts
•  Keeping a list of your products of interest
•  Saving all of your favorite pages on the site*
•  Accessing restricted content

*Save favorites by clicking the star () in the top right corner of each page while you're logged in.

Create an account to get started

  • BioView blog
  • Automation
  • Cancer research
  • Career spotlights
  • Current events
  • Customer stories
  • Gene editing
  • Research news
  • Single-cell analysis
  • Stem cell research
  • Tips and troubleshooting
  • Women in STEM
  • That's Good Support!
  • About our blog
  • That's Good Science!
  • SMART-Seq Pro Biomarker Discovery Contest
  • DNA extraction educational activity
  • That's Good Science Podcast
  • Season one
  • Season two
  • Season three
  • Our brands
  • Our history
  • In the news
  • Events
  • Biomarker discovery events
  • Calendar
  • Conferences
  • Speak with us
  • Careers
  • Company benefits
  • Trademarks
  • License statements
  • Quality statement
  • HQ-grade reagents
  • International Contacts by Region
  • United States and Canada
  • China
  • Japan
  • Korea
  • Europe
  • India
  • Affiliates & distributors
  • Need help?
  • Privacy request
  • Website FAQs

That's GOOD Science!

What does it take to generate good science? Careful planning, dedicated researchers, and the right tools. At Takara Bio, we thoughtfully develop exceptional products to tackle your most challenging research problems, and have an expert team of technical support professionals to help you along the way, all at superior value.

Explore what makes good science possible

 Customer Login
 View Cart (0)
Takara Bio
  • Home
  • Products
  • Services & Support
  • Learning centers
  • APPLICATIONS
  • About
  • Contact Us
  •  Customer Login
  • Register
  •  View Cart (0)

Takara Bio USA, Inc. provides kits, reagents, instruments, and services that help researchers explore questions about gene discovery, regulation, and function. As a member of the Takara Bio Group, Takara Bio USA is part of a company that holds a leadership position in the global market and is committed to improving the human condition through biotechnology. Our mission is to develop high-quality innovative tools and services to accelerate discovery.

FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC PROCEDURES (EXCEPT AS SPECIFICALLY NOTED).

Clontech, TaKaRa, cellartis

  • Products
  • COVID-19 research
  • Next-generation sequencing
  • Real-time PCR
  • Stem cell research
  • mRNA and cDNA synthesis
  • PCR
  • Cloning
  • Nucleic acid purification
  • Gene function
  • Protein research
  • Antibodies and ELISA
  • New products
  • Special offers
  • COVID-19 research
  • Viral detection with qPCR
  • SARS-CoV-2 pseudovirus
  • Human ACE2 stable cell line
  • Viral RNA isolation
  • Viral and host sequencing
  • Vaccine development
  • CRISPR screening
  • Drug discovery
  • Immune profiling
  • Publications
  • Next-generation sequencing
  • Spatial omics
  • RNA-seq
  • DNA-seq
  • Single-cell NGS automation
  • Reproductive health
  • Bioinformatics tools
  • Immune profiling
  • Real-time PCR
  • Great value master mixes
  • Signature enzymes
  • High-throughput real-time PCR solutions
  • Detection assays
  • References, standards, and buffers
  • Stem cell research
  • Media, differentiation kits, and matrices
  • Stem cells and stem cell-derived cells
  • mRNA and cDNA synthesis
  • In vitro transcription
  • cDNA synthesis kits
  • Reverse transcriptases
  • RACE kits
  • Purified cDNA & genomic DNA
  • Purified total RNA and mRNA
  • PCR
  • Most popular polymerases
  • High-yield PCR
  • High-fidelity PCR
  • GC rich PCR
  • PCR master mixes
  • Cloning
  • In-Fusion seamless cloning
  • Competent cells
  • Ligation kits
  • Restriction enzymes
  • Nucleic acid purification
  • Automated platforms
  • Plasmid purification kits
  • Genomic DNA purification kits
  • DNA cleanup kits
  • RNA purification kits
  • Gene function
  • Gene editing
  • Viral transduction
  • Fluorescent proteins
  • T-cell transduction and culture
  • Tet-inducible expression systems
  • Transfection reagents
  • Cell biology assays
  • Protein research
  • Purification products
  • Two-hybrid and one-hybrid systems
  • Mass spectrometry reagents
  • Antibodies and ELISA
  • Primary antibodies and ELISAs by research area
  • Fluorescent protein antibodies
  • Services & Support
  • OEM
  • Instrument services
  • Gene and cell therapy manufacturing
  • Customer service
  • Sales
  • Shipping & delivery
  • Technical support
  • Feedback
  • Online tools
  • Partnering & Licensing
  • Vector information
  • OEM
  • Portfolio
  • Process
  • Facilities
  • Request samples
  • FAQs
  • Instrument services
  • Apollo services
  • ICELL8 services
  • SmartChip ND system services
  • Gene and cell therapy manufacturing
  • Services
  • Facilities
  • Our process
  • Resources
  • Sales
  • Make an appointment with your sales rep
  • Online tools
  • GoStix Plus FAQs
  • Vector information
  • Vector document overview
  • Vector document finder
  • Learning centers
  • Automation systems
  • Next-generation sequencing
  • Spatial biology
  • Real-time PCR
  • Nucleic acid purification
  • mRNA and cDNA synthesis
  • PCR
  • Cloning
  • Stem cell research
  • Gene function
  • Protein research
  • Antibodies and ELISA
  • Automation systems
  • Shasta Single Cell System introduction
  • SmartChip Real-Time PCR System introduction
  • ICELL8 introduction
  • Next-generation sequencing
  • RNA-seq
  • Technical notes
  • Technology and application overviews
  • FAQs and tips
  • DNA-seq protocols
  • Bioinformatics resources
  • Webinars
  • Real-time PCR
  • Download qPCR resources
  • Overview
  • Reaction size guidelines
  • Guest webinar: extraction-free SARS-CoV-2 detection
  • Technical notes
  • Nucleic acid purification
  • Nucleic acid extraction webinars
  • Product demonstration videos
  • Product finder
  • Plasmid kit selection guide
  • RNA purification kit finder
  • mRNA and cDNA synthesis
  • mRNA synthesis
  • cDNA synthesis
  • PCR
  • Citations
  • PCR selection guide
  • Technical notes
  • FAQ
  • Cloning
  • Automated In-Fusion Cloning
  • In-Fusion Cloning general information
  • Primer design and other tools
  • In‑Fusion Cloning tips and FAQs
  • Applications and technical notes
  • Stem cell research
  • Overview
  • Protocols
  • Technical notes
  • Gene function
  • Gene editing
  • Viral transduction
  • T-cell transduction and culture
  • Inducible systems
  • Cell biology assays
  • Protein research
  • Capturem technology
  • Antibody immunoprecipitation
  • His-tag purification
  • Other tag purification
  • Expression systems
  • APPLICATIONS
  • Molecular diagnostics
  • mRNA and protein therapeutics
  • Pathogen detection
  • Immunotherapy research
  • Cancer research
  • Alzheimer's disease research
  • Reproductive health technologies
  • Infectious diseases
  • Molecular diagnostics
  • Interview: adapting to change with Takara Bio
  • Applications
  • Solutions
  • Partnering
  • Contact us
  • mRNA and protein therapeutics
  • Characterizing the viral genome and host response
  • Identifying and cloning protein targets
  • Expressing and purifying protein targets
  • Immunizing mice and optimizing vaccines
  • Pathogen detection
  • Sample prep
  • Detection methods
  • Identification and characterization
  • SARS-CoV-2
  • Antibiotic-resistant bacteria
  • Food crop pathogens
  • Waterborne disease outbreaks
  • Viral-induced cancer
  • Immunotherapy research
  • T-cell therapy
  • Antibody therapeutics
  • T-cell receptor profiling
  • TBI initiatives in cancer therapy
  • Cancer research
  • Kickstart your cancer research with long-read sequencing
  • Sample prep from FFPE tissue
  • Sample prep from plasma
  • Cancer biomarker quantification
  • Single cancer cell analysis
  • Cancer transcriptome analysis
  • Cancer genomics and epigenomics
  • HLA typing in cancer
  • Gene editing for cancer therapy/drug discovery
  • Alzheimer's disease research
  • Antibody engineering
  • Sample prep from FFPE tissue
  • Single-cell sequencing
  • Reproductive health technologies
  • Embgenix FAQs
  • Preimplantation genetic testing
  • ESM partnership program
  • ESM Collection Kit forms
  • Infectious diseases
  • Develop vaccines for HIV
  • About
  • BioView blog
  • That's Good Science!
  • Our brands
  • Our history
  • In the news
  • Events
  • Careers
  • Trademarks
  • License statements
  • Quality and compliance
  • HQ-grade reagents
  • International Contacts by Region
  • Need help?
  • Website FAQs
  • BioView blog
  • Automation
  • Cancer research
  • Career spotlights
  • Current events
  • Customer stories
  • Gene editing
  • Research news
  • Single-cell analysis
  • Stem cell research
  • Tips and troubleshooting
  • Women in STEM
  • That's Good Support!
  • About our blog
  • That's Good Science!
  • SMART-Seq Pro Biomarker Discovery Contest
  • DNA extraction educational activity
  • That's Good Science Podcast
  • Season one
  • Season two
  • Season three
  • Events
  • Biomarker discovery events
  • Calendar
  • Conferences
  • Speak with us
  • Careers
  • Company benefits
  • International Contacts by Region
  • United States and Canada
  • China
  • Japan
  • Korea
  • Europe
  • India
  • Affiliates & distributors
  • Need help?
  • Privacy request
Takara Bio
  • Products
  • Services & Support
  • Learning centers
  • APPLICATIONS
  • About
  • Contact Us